| 000 | 01512 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515002432.0 | ||
| 264 | 0 | _c20051202 | |
| 008 | 200512s 0 0 eng d | ||
| 022 | _a1042-8194 | ||
| 024 | 7 |
_a10.1080/10428190500204781 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBatlle, Montserrat | |
| 245 | 0 | 0 |
_aUsefulness of tumor markers CA 125 and CA 15.3 at diagnosis and during follow-up in non-Hodgkin's lymphoma: study of 200 patients. _h[electronic resource] |
| 260 |
_bLeukemia & lymphoma _cOct 2005 |
||
| 300 |
_a1471-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aCA-125 Antigen _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMucin-1 _xblood |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aRibera, Josep-Maria | |
| 700 | 1 | _aOriol, Albert | |
| 700 | 1 | _aPastor, Cruz | |
| 700 | 1 | _aMate, José-Luis | |
| 700 | 1 | _aFernández-Avilés, Francesc | |
| 700 | 1 | _aFlores, Alonso | |
| 700 | 1 | _aMillá, Fuensanta | |
| 700 | 1 | _aFeliu, Evarist | |
| 773 | 0 |
_tLeukemia & lymphoma _gvol. 46 _gno. 10 _gp. 1471-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/10428190500204781 _zAvailable from publisher's website |
| 999 |
_c15825417 _d15825417 |
||